Overview
Status
Active
Registry date
2015-12-04
Share capital
100,000.00 PLN
Registered address
ul. Szwedzka 2A, 42-600 Tarnowskie Góry, Poland
Electronic delivery address
AE:PL-19349-69231-ACSTS-34
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $2,463 |
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 33 days late).
- 202530/06/2026
- 202430/06/2025
- 202312/07/2024
- 202215/07/2023
- 202117/08/2022
- 202027/06/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Division · Manufacture of basic pharmaceutical products and pharmaceutical preparations186 / 231
Top 81%
Results vs industry
Revenue
This companyUSD 53.37kMedianUSD 165.97kAverageUSD 2.30m
Net profit
This companyUSD 33.68kMedianUSD 1.32kAverageUSD 109.80k
Operating costs
This companyUSD 16.80kMedianUSD 201.81kAverageUSD 2.10m
Assets
This companyUSD 183.21kMedianUSD 118.27kAverageUSD 1.54m
Industry
Authorized Representatives
Tomasz Michał Jaros – President of the Management Board
Manner of representation
Each member of the management board acting independently is authorized to make and sign declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Magdalena Wiktoria Jarosage 18 | 1,000 | – | 50% |
Tomasz Michał Jarosage 48 | 1,000 | – | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Dyllasp. z o.o. | 4,727.17 USD | 17.5% |
Bank accounts
Registered as a VAT taxpayer on 2020-10-01.
59 1050 1298 1000 0090 3074 0204
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| BIO Animalisp. z o.o. | $49,176.96 | proanimali.com | ||
| Ampliconsp. z o.o. | $48,330.99 | amplicon.pl | ||
| Xenira Pharmaceuticalssp. z o.o. | $26,670.82 | xenirapharma.com | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Grupa FinepharmS.A. | – | finepharm.pl |
FAQ
The main business activity of Leki w Niskiej Cenie Pefarm focuses on manufacture of basic pharmaceutical products.
The company was registered in the Polish National Court Register (KRS) on December 4, 2015.
The headquarters is located at: ul. Szwedzka 2A, 42-600 Tarnowskie Góry.
The share capital of the company is PLN 100,000 (approx. $27,012).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of $53,371 in 2025, which is an increase of 395.0% compared to 2024.
Yes, in 2025 the company was profitable, achieving a net profit of $33,682.
The largest operating cost category falls under external services. This category amounted to $9,556 in 2025, representing 57% of all operating expenses.
Last updated: 2026-10-04